US Patent Issued to BLUESTONE PHARMA, BLIS TECHNOLOGIES on Aug. 25 for "Production of a probiotic composition" (Austrian, Spanish Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,731, issued on Aug. 25, was assigned to BLUESTONE PHARMA GMBH (Baar, Switzerland) and BLIS TECHNOLOGIES Ltd. (Dunedin, New Zealand).

"Production of a probiotic composition" was invented by Elisabeth Kirl (Bruck an der Mur, Austria), Bernhard Hofbauer (Murzzuschlag, Austria), Michael Faber (Sitges, Spain) and Karsten Brandt (Sitges, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method of producing a freeze-dried probiotic composition as well as a method of producing a probiotic raw material which involves culturing of a Streptococcus salivarius strain. Furthermore, a corresponding probiotic composition and a corresponding probiot...